Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Fujifilm Holdings Corp | 28 |
| 2 | Government of the United States of America | 19 |
| 3 | Leland Stanford Junior University | 18 |
| 4 | Cincinnati Children's Hospital Medical Center | 14 |
| 5 | Kyoto University | 8 |
| 6 | RIKEN | 8 |
| 7 | Centre National de la Recherche Scientifique | 6 |
| 8 | Genus PLC | 6 |
| 9 | Sumitomo Chemical Co Ltd | 6 |
| 10 | Mass General Brigham Inc | 5 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | C12N | Microorganisms, enzymes | 209 |
| 2 | A61K | Medicinal preparations | 163 |
| 3 | A61P | Therapeutic activity (drug indications) | 129 |
| 4 | G01N | Investigating / analysing materials | 65 |
| 5 | C07K | Peptides | 43 |
| 6 | A61L | Sterilising / disinfecting materials | 29 |
| 7 | C12Q | Measuring/testing involving enzymes | 24 |
| 8 | Y02A | Climate change adaptation | 17 |
| 9 | C08L | Polymer compositions (blends) | 12 |
| 10 | A01K | 9 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee |
|---|---|---|
| Application of FH535 as medicine for promoting differentiation of ADSCs into liver cells | 2024 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2016 | 5 |
| 2017 | 5 |
| 2018 | 5 |
| 2019 | 5 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Roberto Gedaly | University of Kentucky | 6 |
| 2 | Brett T. Spear | University of Kentucky | 5 |
| 3 | Jieyun Jiang | University of Kentucky | 3 |
| 4 | David S. Watt | University of Kentucky | 3 |
| 5 | Vitaliy M. Sviripa | University of Kentucky | 2 |
| 6 | Stefano Gianni | Istituto Pasteur | 2 |
| 7 | Fei‐Ran Gong | Soochow University | 2 |
| 8 | Alexis Grande | University of Modena and Reggio Emilia | 2 |
| 9 | Roberto Galuppo | University of Kentucky | 2 |
| 10 | Chunsheng Kang | Tianjin Medical University General Hospital | 2 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype | 2015 | 329 | Epigenetics and DNA Methylation |
| A small-molecule inhibitor of Tcf/β-catenin signaling down-regulates PPARγ and PPARδ activities | 2008 | 181 | Peroxisome Proliferator-Activated Receptors |
| Cadmium induces carcinogenesis in BEAS-2B cells through ROS-dependent activation of PI3K/AKT/GSK-3β/β-catenin signaling | 2012 | 126 | Heavy Metal Exposure and Toxicity |
| Targeting the Wnt/β-Catenin Signaling Pathway in Liver Cancer Stem Cells and Hepatocellular Carcinoma Cell Lines with FH535 | 2014 | 118 | Wnt/β-catenin signaling in development and cancer |
| Inhibitory Effects of Bisphenol-A on Neural Stem Cells Proliferation and Differentiation in the Rat Brain Are Dependent on Wnt/β-Catenin Pathway | 2014 | 114 | Pluripotent Stem Cells Research |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of FH535?
Which organizations hold the most patents related to FH535?
What research areas are most commonly associated with FH535 patents?
How has publication and patent activity for FH535 changed in recent years?
What is the primary research focus of leading FH535 authors?